In vitro activity of silver sulfadiazine against Herpesvirus hominis.
Silver sulfadiazine, at a concentration of 10 mug/ml, inhibits Herpesvirus hominis types 1 and 2 in vitro. The antiviral effect is directly related to concentration of the drug and duration of exposure.